Urelumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Urelumab Usage And Synthesis

Biological Activity

Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma. Urelumab is a fully human antibody that targets CD137. The antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with Medarex.

target

4-1BB

Urelumab(934823-49-1)Related Product Information

• varlilumab
• Eptinezumab
• Atezolizumab
• Obinutuzumab
• Sutimlimab
• Utomilumab
• Glofitamab
• Nesvacumab
• Odronextamab
• Rituximab